Novartis announced an increase in investment in China, with an expected investment exceeding 3.3 billion yuan.

The 2026 China Development Forum was grandly opened in Beijing. During the event, Novartis announced that it will continue to increase its investment in China, expand its research and development, production, and operation layout in China, and is expected to invest more than 3.3 billion yuan to support the innovation and high-quality development of the biomedical industry in China.